Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 32, Pages 3583-3616
Publisher
Baishideng Publishing Group Inc.
Online
2018-08-27
DOI
10.3748/wjg.v24.i32.3583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Interim safety and clinical activity in patients (pts) with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma from a multicohort phase 1 study of ramucirumab (R) plus pembrolizumab (P).
- (2017) Ian Chau et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkmate 649: A randomized, multicenter, open-label, phase 3 study of nivolumab (Nivo) plus ipilimumab (Ipi) versus oxaliplatin plus fluoropyrimidine in patients (Pts) with previously untreated advanced or metastatic gastric (G) or gastroesophageal junction (GEJ) cancer.
- (2017) Yelena Yuriy Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 1b/2, open label, dose-escalation study of margetuximab (M) in combination with pembrolizumab (P) in patients with relapsed/refractory advanced HER2+ gastroesophageal (GEJ) junction or gastric (G) cancer.
- (2017) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
- (2017) Zin W. Myint et al. Journal of Hematology & Oncology
- PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
- (2017) Jun Wang et al. Journal of Hematology & Oncology
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
- (2017) Jing Ma et al. Oncotarget
- The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
- (2017) Hirokazu Shoji et al. Oncotarget
- Immunotherapy in Gastrointestinal Cancers
- (2017) Letizia Procaccio et al. Biomed Research International
- Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer
- (2017) Kecheng Zhang et al. Journal of Cancer
- Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer
- (2017) Wenfeng Fang et al. Journal of Cancer
- Medical management of gastric cancer: a 2017 update
- (2017) Nikolaos Charalampakis et al. Cancer Medicine
- Immunotherapy for gastric cancers: emerging role and future perspectives
- (2017) Marta Bonotto et al. Expert Review of Clinical Pharmacology
- The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
- (2017) Christine Böger et al. OncoImmunology
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
- (2017) Byung Woog Kang et al. World Journal of Gastrointestinal Oncology
- Molecular classifications of gastric cancers: Novel insights and possible future applications
- (2017) Silvio Ken Garattini et al. World Journal of Gastrointestinal Oncology
- The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer
- (2017) Ahmet Dirican et al. Cancer Biomarkers
- PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
- (2017) Lihu Gu et al. PLoS One
- Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
- (2016) Changqing Ma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients
- (2016) Akihito Kawazoe et al. Gastric Cancer
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Phase Ib study of pembrolizumab in combination with bevacizumab for the treatment of metastatic renal cell carcinoma: Big Ten Cancer Research Consortium BTCRC-GU14-003.
- (2016) Arkadiusz Z. Dudek et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, PD-L1 expression, and clinical activity of avelumab (MSB0010718C), an anti-PD-L1 antibody, in Japanese patients with advanced gastric or gastroesophageal junction cancer.
- (2016) Tomohiro Nishina et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Phase 3 KEYNOTE-061 study.
- (2016) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results for the advanced esophageal carcinoma cohort of the phase Ib KEYNOTE-028 study of pembrolizumab (MK-3475).
- (2016) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer
- (2016) Congqi Dai et al. Molecular Oncology
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer
- (2016) Byungho Lim WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
- (2016) Xiao-Shan Feng et al. OncoTargets and Therapy
- The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients
- (2016) Han Sol Choi et al. Oncotarget
- PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
- (2016) Christine Böger et al. Oncotarget
- Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
- (2016) Hyeyoon Chang et al. Oncotarget
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
- (2016) Minghui Zhang et al. Scientific Reports
- Prognostic value of tumor-infiltrating lymphocytes in Epstein–Barr virus-associated gastric cancer
- (2015) B. W. Kang et al. ANNALS OF ONCOLOGY
- Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity
- (2015) M. Derouazi et al. CANCER RESEARCH
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
- (2015) L. Zhai et al. CLINICAL CANCER RESEARCH
- Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma
- (2015) Jiuwei Cui et al. CYTOTHERAPY
- Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma
- (2015) Patrick Tan et al. GASTROENTEROLOGY
- Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes
- (2015) Sun Young Kim et al. GASTROENTEROLOGY
- Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in Gastric Cancer
- (2015) Feng Xu et al. MEDICINE
- Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer
- (2015) Kai Liu et al. MEDICINE
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Prolonged overall survival in gastric cancer patients after adoptive immunotherapy
- (2015) Guo-Qing Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Gastric cancer and the epoch of immunotherapy approaches
- (2015) Elena Niccolai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
- (2015) Benling Xu et al. Oncotarget
- Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
- (2015) Simon Gebremeskel et al. Oncotarget
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients
- (2015) Audrey Hennequin et al. OncoImmunology
- Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma
- (2015) Hans A. Schlößer et al. OncoImmunology
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Phase Ib/II study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) and tremelimumab as monotherapy or in combination, in patients with recurrent or metastatic gastric/gastroesophageal junction adenocarcinoma
- (2015) Ronan J Kelly et al. Journal for ImmunoTherapy of Cancer
- Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
- (2015) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- PD-L1 and Survival in Solid Tumors: A Meta-Analysis
- (2015) Pin Wu et al. PLoS One
- Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma
- (2015) Kyung-Ju Kim et al. PLoS One
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey
- (2014) Giuseppe Aprile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
- (2014) Jin Won Kim et al. Gastric Cancer
- Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
- (2014) Suling J Lin et al. GUT
- Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer
- (2014) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
- (2014) YOSHIE HIGASHIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Decreased density of CD3+ tumor-infiltrating lymphocytes during gastric cancer progression
- (2014) Takaaki Arigami et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Analysis of Promoter Methylation, Polymorphism and Expression Profile of Cytotoxic T-Lymphocyte-Associated Antigen-4 in Patients with Gastric Cancer
- (2014) Journal of Gastrointestinal and Liver Diseases
- Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer
- (2014) Sebastian Kobold et al. JNCI-Journal of the National Cancer Institute
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Causes and consequences of microsatellite instability in gastric carcinogenesis
- (2014) Sérgia Velho WORLD JOURNAL OF GASTROENTEROLOGY
- Immunotherapy in gastric cancer
- (2014) Satoko Matsueda WORLD JOURNAL OF GASTROENTEROLOGY
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
- (2014) Ikuo Wada et al. Cancer Medicine
- Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors
- (2014) Clara E. Jäkel et al. Journal of Immunology Research
- Control of the Immune Response by Pro-Angiogenic Factors
- (2014) Thibault Voron et al. Frontiers in Oncology
- Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) T. Waddell et al. ANNALS OF ONCOLOGY
- Current clinical trials with polo-like kinase 1 inhibitors in solid tumors
- (2013) Hyungshin Yim ANTI-CANCER DRUGS
- Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients
- (2013) Hua Zhao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil
- (2013) Zhengdeng Lei et al. GASTROENTEROLOGY
- Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
- (2013) Kyung-Ju Kim et al. HUMAN PATHOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- The enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells
- (2013) Xiao-Ting Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancer
- (2013) KOHEI WAKATSUKI et al. ONCOLOGY REPORTS
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- CCR7 Expression and Intratumoral FOXP3+ Regulatory T Cells are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer
- (2013) Shuang Zhou et al. PLoS One
- Association between CTLA-4 60G/A and -1661A/G Polymorphisms and the Risk of Cancers: A Meta-Analysis
- (2013) Qing Yan et al. PLoS One
- Bone Marrow-Derived Mesenchymal Stem Cells Favor the Immunosuppressive T Cells Skewing in a Helicobacter Pylori Model of Gastric Cancer
- (2013) Rong Lin et al. STEM CELLS AND DEVELOPMENT
- Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide
- (2012) Yi Gang et al. Biochemistry and Cell Biology
- Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer
- (2012) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
- (2012) Liangrong Shi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients
- (2012) Hiroaki Saito et al. Gastric Cancer
- Mice That Express Human Interleukin-8 Have Increased Mobilization of Immature Myeloid Cells, Which Exacerbates Inflammation and Accelerates Colon Carcinogenesis
- (2012) Samuel Asfaha et al. GASTROENTEROLOGY
- Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma
- (2012) Amedeo Amedei et al. Internal and Emergency Medicine
- Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
- (2012) TORU MASUZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Increased Circulating Th22 and Th17 Cells are Associated with Tumor Progression and Patient Survival in Human Gastric Cancer
- (2012) Tao Liu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
- (2012) Hiroaki Saito et al. JOURNAL OF SURGICAL ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer
- (2012) SHINJI OHKI et al. ONCOLOGY REPORTS
- In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model
- (2012) XIAOHUI DU et al. ONCOLOGY REPORTS
- Preparation and antitumor effects of nanovaccines with MAGE-3 peptides in transplanted gastric cancer in mice
- (2012) Jun Yang et al. Chinese Journal of Cancer
- Ipilimumab: A Novel Treatment for Metastatic Melanoma
- (2011) Morgan E Culver et al. ANNALS OF PHARMACOTHERAPY
- Association of Intra-tumoral Infiltrating Macrophages and Regulatory T Cells Is an Independent Prognostic Factor in Gastric Cancer after Radical Resection
- (2011) Bo Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
- (2011) M C Camargo et al. BRITISH JOURNAL OF CANCER
- Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
- (2011) J. H. Kim et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection
- (2011) Bijan Raziorrouh et al. GASTROENTEROLOGY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells
- (2010) Yeon Jin Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN
- (2010) Jin Hee Kim et al. IMMUNOLOGY LETTERS
- Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer
- (2010) Zhengbin Shen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro
- (2010) Qun Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficient Eradication of Subcutaneous but Not of Autochthonous Gastric Tumors by Adoptive T Cell Transfer in an SV40 T Antigen Mouse Model
- (2010) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients
- (2010) Hideyuki Ubukata et al. JOURNAL OF SURGICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response
- (2010) Mori ONCOLOGY REPORTS
- Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients
- (2010) Jing-Ting Jiang WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
- (2009) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia
- (2009) Matthias Haas et al. BMC GASTROENTEROLOGY
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Evidence of tumor microsatellite instability in gastric cancer with familial aggregation
- (2009) Corrado Pedrazzani et al. Familial Cancer
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location
- (2009) Gwen Murphy et al. GASTROENTEROLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
- (2008) H E Lee et al. BRITISH JOURNAL OF CANCER
- Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
- (2008) Giuseppe Perrone et al. EUROPEAN JOURNAL OF CANCER
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Understanding PTEN regulation: PIP2, polarity and protein stability
- (2008) N R Leslie et al. ONCOGENE
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started